226 related articles for article (PubMed ID: 7503813)
1. EWS/Fli-1 chimeric protein is a transcriptional activator.
Ohno T; Rao VN; Reddy ES
Cancer Res; 1993 Dec; 53(24):5859-63. PubMed ID: 7503813
[TBL] [Abstract][Full Text] [Related]
2. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene.
Lessnick SL; Braun BS; Denny CT; May WA
Oncogene; 1995 Feb; 10(3):423-31. PubMed ID: 7845667
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the DNA-binding and transcriptional activation functions of human Fli-1 protein.
Rao VN; Ohno T; Prasad DD; Bhattacharya G; Reddy ES
Oncogene; 1993 Aug; 8(8):2167-73. PubMed ID: 8336942
[TBL] [Abstract][Full Text] [Related]
4. The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains.
Ohno T; Ouchida M; Lee L; Gatalica Z; Rao VN; Reddy ES
Oncogene; 1994 Oct; 9(10):3087-97. PubMed ID: 8084618
[TBL] [Abstract][Full Text] [Related]
5. Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts.
Ouchida M; Ohno T; Fujimura Y; Rao VN; Reddy ES
Oncogene; 1995 Sep; 11(6):1049-54. PubMed ID: 7566963
[TBL] [Abstract][Full Text] [Related]
6. The EWS-ATF-1 gene involved in malignant melanoma of soft parts with t(12;22) chromosome translocation, encodes a constitutive transcriptional activator.
Fujimura Y; Ohno T; Siddique H; Lee L; Rao VN; Reddy ES
Oncogene; 1996 Jan; 12(1):159-67. PubMed ID: 8552387
[TBL] [Abstract][Full Text] [Related]
7. Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids.
Athanasiou M; LeGallic L; Watson DK; Blair DG; Mavrothalassitis G
Cancer Gene Ther; 2000 Aug; 7(8):1188-95. PubMed ID: 10975680
[TBL] [Abstract][Full Text] [Related]
8. Fli-1b is generated by usage of differential splicing and alternative promoter.
Dhulipala PD; Lee L; Rao VN; Reddy ES
Oncogene; 1998 Sep; 17(9):1149-57. PubMed ID: 9764825
[TBL] [Abstract][Full Text] [Related]
9. Biphenotypic sarcomas with myogenic and neural differentiation express the Ewing's sarcoma EWS/FLI1 fusion gene.
Sorensen PH; Shimada H; Liu XF; Lim JF; Thomas G; Triche TJ
Cancer Res; 1995 Mar; 55(6):1385-92. PubMed ID: 7882340
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias.
Yi H; Fujimura Y; Ouchida M; Prasad DD; Rao VN; Reddy ES
Oncogene; 1997 Mar; 14(11):1259-68. PubMed ID: 9178886
[TBL] [Abstract][Full Text] [Related]
11. A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1.
Jeon IS; Davis JN; Braun BS; Sublett JE; Roussel MF; Denny CT; Shapiro DN
Oncogene; 1995 Mar; 10(6):1229-34. PubMed ID: 7700648
[TBL] [Abstract][Full Text] [Related]
12. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG.
Sorensen PH; Lessnick SL; Lopez-Terrada D; Liu XF; Triche TJ; Denny CT
Nat Genet; 1994 Feb; 6(2):146-51. PubMed ID: 8162068
[TBL] [Abstract][Full Text] [Related]
13. EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells.
Tanaka K; Iwakuma T; Harimaya K; Sato H; Iwamoto Y
J Clin Invest; 1997 Jan; 99(2):239-47. PubMed ID: 9005992
[TBL] [Abstract][Full Text] [Related]
14. EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro.
Kovar H; Aryee DN; Jug G; Henöckl C; Schemper M; Delattre O; Thomas G; Gadner H
Cell Growth Differ; 1996 Apr; 7(4):429-37. PubMed ID: 9052984
[TBL] [Abstract][Full Text] [Related]
15. The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties.
Bertolotti A; Bell B; Tora L
Oncogene; 1999 Dec; 18(56):8000-10. PubMed ID: 10637511
[TBL] [Abstract][Full Text] [Related]
16. EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene.
Thompson AD; Braun BS; Arvand A; Stewart SD; May WA; Chen E; Korenberg J; Denny C
Oncogene; 1996 Dec; 13(12):2649-58. PubMed ID: 9000139
[TBL] [Abstract][Full Text] [Related]
17. A new member of the ETS family fused to EWS in Ewing tumors.
Peter M; Couturier J; Pacquement H; Michon J; Thomas G; Magdelenat H; Delattre O
Oncogene; 1997 Mar; 14(10):1159-64. PubMed ID: 9121764
[TBL] [Abstract][Full Text] [Related]
18. [Detection of EWS-/FLI-1 gene fusion transcripts by RT-PCR as a tool in the diagnosis of tumors of the Ewing sarcoma group].
Dockhorn-Dworniczak B; Schäfer KL; Dantcheva R; Blasius S; van Valen F; Burdach S; Winkelmann W; Jürgens J; Böcker W
Verh Dtsch Ges Pathol; 1994; 78():214-9. PubMed ID: 7533989
[TBL] [Abstract][Full Text] [Related]
19. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members.
Zhang L; Lemarchandel V; Romeo PH; Ben-David Y; Greer P; Bernstein A
Oncogene; 1993 Jun; 8(6):1621-30. PubMed ID: 8502483
[TBL] [Abstract][Full Text] [Related]
20. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements.
Watson DK; Robinson L; Hodge DR; Kola I; Papas TS; Seth A
Oncogene; 1997 Jan; 14(2):213-21. PubMed ID: 9010223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
